active glp-1 Enrolling trial: agonist therapy in cystic fibrosis The conversation around GLP-1 medications

One of the challenges that I think that were going to have is payer reimbursement, DeRoo added

The mechanism that slows gastric emptying, believed to cause gastroparesis, is present in both semaglutide and tirzepatide drugs

However, the issue of weight loss is layered and ultimately unique on an individual basis

It is crucial to understand that findings in animal studies do not automatically translate to human risk

Routine monitoring for thyroid cancer is not recommended by guidelines, but any concerning symptoms should be taken seriously and promptly assessed by a healthcare provider

While these drugs were initially developed to manage type 2 diabetes, theyve proven beneficial for women with PCOS by addressing the metabolic dysfunction that underpins the condition